BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2867528)

  • 1. Steady state levels of pro-dynorphin-related end products in the striatum and substantia nigra of the adult rhesus monkey.
    Dores RM; Akil H
    Peptides; 1985; 6 Suppl 2():143-8. PubMed ID: 2867528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of opioid and non-opioid end products of pro-dynorphin in the substantia nigra of the rat.
    Dores RM; Lewis ME; Khachaturian H; Watson SJ; Akil H
    Neuropeptides; 1985 Feb; 5(4-6):501-4. PubMed ID: 2860608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the processing of pro-dynorphin end products in the substantia nigra during neonatal development.
    Sei CA; Dores RM
    Peptides; 1990; 11(1):89-94. PubMed ID: 2342993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prodynorphin-derived peptide expression in primate cortex and striatum.
    Healy DJ; Meador-Woodruff JH
    Neuropeptides; 1994 Nov; 27(5):277-84. PubMed ID: 7862260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible interactions between dynorphin and dopaminergic systems in rat basal ganglia and substantia nigra.
    Quirion R; Gaudreau P; Martel JC; St-Pierre S; Zamir N
    Brain Res; 1985 Apr; 331(2):358-62. PubMed ID: 2859094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of prodynorphin end products in lizard, turtle, and alligator brain extracts.
    Goldsmith AM; Sei CA; Lance V; Dores RM
    Peptides; 1992; 13(3):435-40. PubMed ID: 1355904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential metabolism of dynorphins in substantia nigra, striatum, and hippocampus.
    Sandin J; Tan-No K; Kasakov L; Nylander I; Winter A; Silberring J; Terenius L
    Peptides; 1997; 18(7):949-56. PubMed ID: 9357051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prodynorphin peptide distribution in the forebrain of the Syrian hamster and rat: a comparative study with antisera against dynorphin A, dynorphin B, and the C-terminus of the prodynorphin precursor molecule.
    Neal CR; Newman SW
    J Comp Neurol; 1989 Oct; 288(3):353-86. PubMed ID: 2571622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional distribution of dynorphin and neo-endorphin peptides in rat brain, spinal cord, and pituitary.
    Cone RI; Weber E; Barchas JD; Goldstein A
    J Neurosci; 1983 Nov; 3(11):2146-52. PubMed ID: 6138396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the origin of dynorphin A and alpha-neo-endorphin in the substantia nigra.
    Palkovits M; Brownstein MJ; Zamir N
    Neuropeptides; 1984 May; 4(3):193-9. PubMed ID: 6146942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ontogenetic development of the pro-enkephalin B (= pro-dynorphin) opioid peptide system in the rat pituitary.
    Seizinger BR; Liebisch DC; Grimm C; Herz A
    Neuroendocrinology; 1984 Nov; 39(5):414-22. PubMed ID: 6151128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of striatonigral prodynorphin peptides by dopaminergic agents.
    Trujillo KA; Day R; Akil H
    Brain Res; 1990 Jun; 518(1-2):244-56. PubMed ID: 1975215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement and chromatographic characterization of prodynorphin-derived peptides in the guinea-pig ileum.
    Steele PA; Turner CA; Murphy R
    Neuropeptides; 1989 Apr; 13(3):207-13. PubMed ID: 2565558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for a selective processing of proenkephalin B into different opioid peptide forms in particular regions of rat brain and pituitary.
    Seizinger BR; Grimm C; Höllt V; Herz A
    J Neurochem; 1984 Feb; 42(2):447-57. PubMed ID: 6141221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynorphin peptides in human substantia nigra.
    Christensson-Nylander I; Terenius L
    Neuropeptides; 1985 Sep; 6(5):391-6. PubMed ID: 2865698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of an endogenous C-terminal fragment of the alpha-neo-endorphin/dynorphin precursor from bovine caudate nucleus.
    Evans CJ; Barchas JD; Esch FS; Böhlen P; Weber E
    J Neurosci; 1985 Jul; 5(7):1803-7. PubMed ID: 2862225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Striato-nigral dynorphin and substance P pathways in the rat. I. Biochemical and immunohistochemical studies.
    Christensson-Nylander I; Herrera-Marschitz M; Staines W; Hökfelt T; Terenius L; Ungerstedt U; Cuello C; Oertel WH; Goldstein M
    Exp Brain Res; 1986; 64(1):169-92. PubMed ID: 2429858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Habenular modulation of dynorphinergic systems in rat ventral mesencephalon.
    Ichikawa H; Nishikawa T; Mitsushio H; Takashima M
    Peptides; 1988; 9(5):1107-14. PubMed ID: 2469061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-neo-endorphin coexists with dynorphin-A(1-8) within intramurally lying perikarya of rat duodenum.
    Wolter HJ
    Peptides; 1986; 7(3):389-92. PubMed ID: 2877446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical evidence for a dynorphin immunoreactive striato-nigral pathway.
    Vincent S; Hökfelt T; Christensson I; Terenius L
    Eur J Pharmacol; 1982 Nov; 85(2):251-2. PubMed ID: 6129987
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.